Find a Commonwealth Resource
Crizanlizumab
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Adakveo (crizanlizumab) is a prescription biologic medication manufactured by Novartis Pharmaceuticals Corporation. It acts as a P-selectin blocker to help manage certain conditions. Administered intravenously as an injection at 10 mg/mL strength. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Crizanlizumab
Access the FDA dataset for Crizanlizumab — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025